Dimensional Fund Advisors LP Cuts Stock Position in Plexus Corp. $PLXS

Dimensional Fund Advisors LP lessened its holdings in Plexus Corp. (NASDAQ:PLXS) by 0.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,366,406 shares of the technology company’s stock after selling 7,829 shares during the period. Dimensional Fund Advisors LP owned approximately 5.06% of Plexus worth $197,701,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. American Century Companies Inc. lifted its position in Plexus by 44.2% during the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after purchasing an additional 338,119 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of Plexus by 7.5% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,955 shares of the technology company’s stock worth $941,000 after buying an additional 484 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Plexus by 23.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 240,192 shares of the technology company’s stock valued at $34,753,000 after buying an additional 45,425 shares in the last quarter. Nicola Wealth Management LTD. purchased a new stake in shares of Plexus during the 3rd quarter valued at about $6,655,000. Finally, Wedge Capital Management L L P NC lifted its holdings in shares of Plexus by 36.6% in the 3rd quarter. Wedge Capital Management L L P NC now owns 27,600 shares of the technology company’s stock valued at $3,993,000 after acquiring an additional 7,393 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Insider Activity

In related news, Chairman Dean A. Foate sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $204.89, for a total transaction of $1,024,450.00. Following the completion of the sale, the chairman directly owned 15,000 shares of the company’s stock, valued at approximately $3,073,350. This trade represents a 25.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Patrick John Jermain sold 4,841 shares of the business’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $204.01, for a total value of $987,612.41. Following the transaction, the chief financial officer owned 20,469 shares of the company’s stock, valued at approximately $4,175,880.69. The trade was a 19.13% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 47,995 shares of company stock valued at $9,718,476. 1.78% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on PLXS shares. Weiss Ratings upgraded Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday. Stifel Nicolaus upped their price objective on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research report on Friday, January 30th. Needham & Company LLC raised their price objective on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. Finally, Benchmark boosted their target price on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $189.20.

Plexus Price Performance

PLXS stock opened at $185.90 on Monday. Plexus Corp. has a 12 month low of $103.43 and a 12 month high of $211.84. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The company has a 50-day moving average price of $183.99 and a 200 day moving average price of $158.22. The stock has a market cap of $4.98 billion, a PE ratio of 28.91 and a beta of 0.81.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, beating the consensus estimate of $1.77 by $0.01. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The firm’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Equities research analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.